It is possible that this finding is due to the fact that those with hepatocellular carcinoma have underlying liver dysfunction; it could also be true that the increased ALT might even function as a marker of efficacy in this setting due to the destruction of malignant hepatocytes. The gene discussed is GPT; the disease is hepatocellular carcinoma.